Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a study titled ‘A Phase 2b/3, Randomized, ...

After 1 year of biologic therapy, admissions requiring noninvasive ventilation among patients with COPD and type 2 ...

For individuals living with COPD, small changes may make a difference. Viatris Inc. and Theravance Biopharma US, Inc. COPD, or chronic obstructive pulmonary disease, is a group of life-changing lung ...

David Mannino is co-founder and chief medical officer of the COPD Foundation. He's an internal medicine doctor with a specialty in pulmonary, critical care, and sleep medicine at University of ...

Among patients with blood eosinophil counts greater than or equal to 150 cells/µL, the reduction in the annual rate of moderate to severe COPD exacerbations was found to be nominally significant. The ...

When breathing becomes a daily battle, even the simplest acts can feel exhausting. Now, a new study has found the key to ...

The development could help scientists develop patient-specific treatments and one day offer a lab-grown lung transplant ...

A new targeted therapy is significantly improving lung cancer patient outcomes. The drug is called Osimertinib, or brand name ...

For individuals living with COPD, small changes may make a difference. Viatris Inc. and Theravance Biopharma US, Inc. COPD, or chronic obstructive pulmonary disease, is a group of life-changing lung ...